Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Protocol: L041M
______________________________________________________________________________

| 592 |L04AA11| ETANERCEPTUM**** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg

SOL. INJ.

ENBREL 25 mg 25 mg WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM PULB + SOLV. PT. 50 mg

SOL. INJ.

ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg

SOL. INJ.

ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
L04AA11 ETANERCEPTUM PULB + SOLV. PT. 50 mg

SOL. INJ.

ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
L04AA11 ETANERCEPTUM SOL. INJ. ÎN SERINGĂ 25 mg

PREUMPLUTĂ

ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
L04AA11 ETANERCEPTUM SOL. INJ. ÎN SERINGĂ 50 mg

PREUMPLUTĂ

ENBREL 50 mg 50 mg WYETH EUROPA LIMITED

________________________________________________________________________________

______________________________________________________________________________

| 593 |L04AA12| INFLIXIMABUM**** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA12 INFLIXIMABUM PULB. PT. CONC. PT. 100 mg

SOL. PERF.

REMICADE 100 mg 100 mg CENTOCOR B.V.

________________________________________________________________________________
______________________________________________________________________________

| 594 |L04AA17| ADALIMUMABUM**** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA17 ADALIMUMABUM SOL. INJ. ÎN SERINGĂ 40 mg

PREUMPLUTĂ

HUMIRA 40 mg 40 mg ABBOTT LABORATORIES LTD.

________________________________________________________________________________
SUBLISTA C1 - G31E ARTRITA JUVENILA.